How to Diagnose Overpacing Before Cutting Bids
A root-cause tree for pharma programmatic overpacing that separates setup, supply, and allocation problems before bids are cut.
The short answer
Overpacing means a campaign is spending faster than planned. Left alone, it runs out of budget early and leaves gaps in coverage. The usual reaction is to cut bids. Sometimes that is right. Often the real cause is a setup error, a supply change, or a budget allocation problem that bid cuts will not fix and may make worse.
The root-cause tree
Branch 1: Setup
- Wrong budget or dates. A typo in the budget or an end date set too early.
- Pacing setting. "As fast as possible" instead of even pacing.
- Time zone mismatch. Daily budgets resetting at unexpected hours.
- Duplicate line items. The same budget running twice.
Check: the DSP change log and settings. These are the most common causes and easiest to fix.
Branch 2: Supply
- New inventory. A deal started delivering at high volume, or open market supply expanded.
- Audience growth. A segment grew after a data refresh.
- Removed restrictions. A blocklist or allowlist was changed.
Check: inventory mix and audience size history. Overpacing from new supply can also mean lower quality.
Branch 3: Allocation
- Budget shifted from another line. A reallocation added more money than intended.
- Underdelivery elsewhere. Automated budget sharing moved funds to this line.
- Plan was too conservative. The audience and inventory support more spend than planned.
Check: the budget allocation history and portfolio-level pacing. The pacing dashboard demo shows portfolio-level pacing views.
Why cutting bids is not always right
| Cause | Effect of cutting bids |
|---|---|
| Setup error | Masks the error; problem returns later |
| New low-quality supply | May shift delivery to even cheaper, lower-quality supply |
| Audience grew | Reduces reach of the new audience |
| Plan too conservative | Leaves value unrealized |
Decide what "on pace" should mean
Pacing targets often assume even spending. Some campaigns should spend faster early, for example around a launch or conference. Confirm the planned pacing curve before calling something overpacing.
Fix and document
- Identify the branch.
- Apply the fix that addresses the cause.
- Check quality and audience delivery after the fix.
- Record the change in the decision log. See weekly optimization.
Practical takeaway
Before cutting bids on an overpacing line, spend ten minutes on the three branches: setup, supply, allocation. Record which branch applied. Patterns across campaigns will show where your process needs tightening.
Sources
External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.
Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.
New pharma programmatic breakdowns, occasionally
One email when I publish something worth reading. Benchmarks, measurement teardowns, and case studies with the caveats attached. No cadence promises, no reselling your address.
Unsubscribe any time. See the privacy policy.
Working through this decision on a real plan?
I work on health and pharma data, identity, and activation, after five years running HCP and DTC programmatic agency-side. Happy to talk through how this applies to your situation.